ASCRIZZI, SERENA
 Distribuzione geografica
Continente #
EU - Europa 151
NA - Nord America 88
AS - Asia 57
SA - Sud America 7
AF - Africa 1
OC - Oceania 1
Totale 305
Nazione #
IT - Italia 102
US - Stati Uniti d'America 84
SG - Singapore 44
DE - Germania 20
FI - Finlandia 12
GB - Regno Unito 8
BR - Brasile 7
HK - Hong Kong 5
IN - India 5
CA - Canada 3
FR - Francia 3
NL - Olanda 3
AT - Austria 2
CN - Cina 1
ES - Italia 1
GT - Guatemala 1
IQ - Iraq 1
KI - Kiribati 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 305
Città #
Singapore 29
Munich 16
Santa Clara 11
Parma 9
Turku 9
Ashburn 8
Rome 8
London 7
Afragola 6
Chicago 6
Naples 6
Hong Kong 5
Melito di Porto Salvo 5
Catania 4
Chandler 4
Santo Stefano di Rogliano 4
Acquaviva delle Fonti 3
Catanzaro 3
Dallas 3
Helsinki 3
Los Angeles 3
Milan 3
San Nicola Manfredi 3
Agrigento 2
Bologna 2
Brescia 2
Brooklyn 2
Campobello di Licata 2
Ercolano 2
Frankfurt am Main 2
Jaraguá do Sul 2
Montreal 2
New York 2
Paris 2
Sorrento 2
West Lafayette 2
Ahmedabad 1
Anaheim 1
Arnhem 1
Aversa 1
Bareilly 1
Bisignano 1
Bismarck 1
Buffalo 1
Cape Town 1
Chennai 1
Columbus 1
Extrema 1
Flint 1
Guatemala City 1
Hanover 1
Hyderabad 1
Iguape 1
Itapetinga 1
Lithonia 1
Manchester 1
New Delhi 1
North York 1
Phoenix 1
Quận Bình Thạnh 1
Ribeira do Pombal 1
San Francisco 1
San Gennaro Vesuviano 1
Seattle 1
Secaucus 1
Soverato Marina 1
Squillace 1
Taquaritinga 1
Taranto 1
Tarawa 1
The Dalles 1
Vallefiorita 1
Washington 1
Totale 221
Nome #
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 85
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer 51
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 45
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 34
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 29
An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myeloma 24
Lynch Syndrome Biopathology and Treatment: The Potential Role of microRNAs in Clinical Practice 19
LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation 14
UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma 12
TERRA G-quadruplex stabilization behind the anti-multiple myeloma activity: Novel insights about resveratrol pleiotropic effects 11
Totale 324
Categoria #
all - tutte 2.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.728


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202358 6 3 0 1 3 0 1 3 3 16 22 0
2023/202460 12 11 4 4 3 15 5 2 0 2 0 2
2024/2025196 13 1 4 3 14 35 10 18 15 3 26 54
2025/202610 10 0 0 0 0 0 0 0 0 0 0 0
Totale 324